Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Clinical Pharmacology and Therapeutics
|
July 8, 2023
Modeling of Proliferating CD4 and CD8 T-Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma
Xuyang Song, Robin Kate Kelley, Michelle Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2022
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
Xuyang Song, Robin Kate Kelley, Anis A Khan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 13, 2023
Mast cell activation and degranulation in acute artery injury: A target for post-operative therapy
Rebecca L Harper, Fang Fang, Hong San, et al.
Circulation Research
|
September 22, 2012
Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy
Jinliang Li, Michael D Kritzer, Jennifer J Carlisle Michel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2024
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma
Bruno Sangro, Peter R Galle, Robin Kate Kelley, et al.
Science Signaling
|
December 15, 2016
Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC
Hui Jin, Cynthia St Hilaire, Yuting Huang, et al.
Science Translational Medicine
|
March 14, 2014
TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling
Brian C Cooley, Jose Nevado, Jason Mellad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2021
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Robin Kate Kelley, Bruno Sangro, William Harris, et al.
Journal of Neuroscience Research
|
August 28, 2007
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells
Ichiro Nakano, Michael Masterman-Smith, Kuniyasu Saigusa, et al.
Journal of Hepatology
|
August 1, 2024
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
George Lau, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Clinical Pharmacology and Therapeutics
|
July 8, 2023
Modeling of Proliferating CD4 and CD8 T-Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma
Xuyang Song, Robin Kate Kelley, Michelle Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2022
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
Xuyang Song, Robin Kate Kelley, Anis A Khan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 13, 2023
Mast cell activation and degranulation in acute artery injury: A target for post-operative therapy
Rebecca L Harper, Fang Fang, Hong San, et al.
Circulation Research
|
September 22, 2012
Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy
Jinliang Li, Michael D Kritzer, Jennifer J Carlisle Michel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2024
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma
Bruno Sangro, Peter R Galle, Robin Kate Kelley, et al.
Science Signaling
|
December 15, 2016
Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC
Hui Jin, Cynthia St Hilaire, Yuting Huang, et al.
Science Translational Medicine
|
March 14, 2014
TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling
Brian C Cooley, Jose Nevado, Jason Mellad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2021
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Robin Kate Kelley, Bruno Sangro, William Harris, et al.
Journal of Neuroscience Research
|
August 28, 2007
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells
Ichiro Nakano, Michael Masterman-Smith, Kuniyasu Saigusa, et al.
Journal of Hepatology
|
August 1, 2024
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
George Lau, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
Page
of 3